Analyst Ranking
Bottom 17%
#4088 out of 4915 analysts
Average Return
-0.88%
Win Rate
48%12 out of 25
Risk vs Reward
Poor
Good

Subbu Nambi's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Natera IncNTRA
+176.34%$60.27$166.55
2023-12-13 -
2024-12-13
Strong Buy
Guardant Health IncGH
+68.11%$28.88$48.55
2024-06-27 -
2025-06-23
Strong Buy
Tempus Ai IncTEM
+41.18%$46.50$65.65
2024-12-08 -
2025-06-23
Strong Buy
Castle Biosciences IncCSTL
+40.08%$20.61$28.87
2023-12-13 -
2024-12-13
Strong Buy
Illumina IncILMN
+19.60%$75.76$90.61
2025-05-08 -
2025-06-23
Strong Buy

Subbu Nambi Analyst Color

Get additional color on Subbu Nambi's coverage of popular stocks

Subbu Nambi's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Illumina IncILMN
3Strong Buy$114.00+25.81%Maintains
a month ago
Twist Bioscience CorpTWST
2Strong Buy$50.00+41.52%Reiterates
2 months ago
Danaher CorpDHR
1Strong Buy$250.00+27.33%Reiterates
2 months ago
Cryoport IncCYRX
1Strong Buy$10.00+52.44%Reiterates
2 months ago
Exact Sciences CorpEXAS
2Strong Buy$60.00+14.20%Reiterates
2 months ago
Neogen CorpNEOG
2Strong Buy$13.00+172.54%Maintains
2 months ago
Veracyte IncVCYT
3Strong Buy$37.00+38.52%Maintains
2 months ago
Guardant Health IncGH
2Strong Buy$56.00+15.35%Reiterates
4 months ago
Natera IncNTRA
2Strong Buy$200.00+17.39%Maintains
5 months ago
Bruker CorpBRKR
1Strong Buy$72.00+85.90%Initiates Coverage On
6 months ago
Tempus Ai IncTEM
1Strong Buy$74.00+12.72%Initiates Coverage On
6 months ago
Sophia Genetics SaSOPH
1Strong Buy$6.00+96.72%Initiates Coverage On
a year ago
Nautilus Biotechnology IncNAUT
1Strong Buy$6.00+763.31%Initiates Coverage On
a year ago
Castle Biosciences IncCSTL
1Strong Buy$25.00N/AInitiates Coverage On
2 years ago
Myriad Genetics IncMYGN
1Strong Buy$23.00N/AInitiates Coverage On
2 years ago
10x Genomics IncTXG
1Strong Buy$60.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.